Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

about

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

Item

http://www.wikidata.org/entity/Q36613979

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

@ast

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

@en

type

Item

label

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

@ast

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

@en

prefLabel

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

@ast

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

@en

P1476

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.

@en

P2093

Edgardo S Santos

http://www.w3.org/2001/XMLSchema#string

Eloy Roman

http://www.w3.org/2001/XMLSchema#string

Luis E Raez

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.

Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck.

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Update on chemoradiotherapy for head and neck cancer.

Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck

P304

1205-1215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.6.9.1205

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17020455

http://www.w3.org/2001/XMLSchema#string